Kempen Capital Management N.V. Abbott Laboratories Transaction History
Kempen Capital Management N.V.
- $7.92 Billion
- Q1 2024
A detailed history of Kempen Capital Management N.V. transactions in Abbott Laboratories stock. As of the latest transaction made, Kempen Capital Management N.V. holds 33,024 shares of ABT stock, worth $3.41 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
33,024
Previous 67,605
51.15%
Holding current value
$3.41 Million
Previous $7.44 Million
49.56%
% of portfolio
0.05%
Previous 0.11%
Shares
11 transactions
Others Institutions Holding ABT
# of Institutions
3,129Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$17.1 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.7 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.67 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.71 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.24 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $181B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...